For a complete list please see here.

Membrane cholesterol access into a G-protein-coupled receptor. Guixà-González R, Albasanz JL, Rodriguez-Espigares I, Pastor M, Sanz F, Martí-Solano M, Manna M, Martinez-Seara H, Hildebrand PW, Martín M, Selent J. Nat Commun. 2017;8:14505.

C-edge loops of arrestin function as a membrane anchor. Lally CC, Bauer B, Selent J, Sommer ME. Nat Commun. 2017;8:14258.

Development of Fluorescent Probes that Target Serotonin 5-HT2B Receptors. Azuaje J, López P, Iglesias A, de la Fuente RA, Pérez-Rubio JM, García D, Stępniewski TM, García-Mera X, Brea JM, Selent J, Pérez D, Castro M, Loza MI, Sotelo E. Sci Rep. 2017;7:10765.

Drugging specific conformational states of GPCRs: challenges and opportunities for computational chemistry. Martí-Solano M, Schmidt D, Kolb P, Selent J. Drug discovery today 2016;21:625-31.

Membrane omega-3 fatty acids modulate the oligomerisation kinetics of adenosine A2A and dopamine D2 receptors. Guixà-González R, Javanainen M, Gómez-Soler M, Cordobilla B, Domingo JC, Sanz F, Pastor M, Ciruela F, Martinez-Seara H, Selent J. Sci Rep. 2016

Detection of new biased agonists for the serotonin 5-HT2A receptor: modeling and experimental validation. Martí-Solano M, Iglesias A, de Fabritiis G, Sanz F, Brea J, Loza MI, Pastor M, Selent J. Mol Pharmacol. 2015;87:740-6.

Novel insights on the structural determinants of clozapine and olanzapine multi-target binding profiles. Selent J, Marti-Solano M, Rodríguez J, Atanes P, Brea J, Castro M, Sanz F, Loza MI, Pastor M. Eur J Med Chem. 2014;77:91-5.

MEMBPLUGIN: studying membrane complexity in VMD. Guixà-González R, Rodriguez-Espigares I, Ramírez-Anguita JM, Carrió-Gaspar P, Martinez-Seara H, Giorgino T, Selent J. Bioinformatics. 2014;30(10):1478-80.

Electronic sculpting of ligand-GPCR subtype selectivity: the case of angiotensin II. Magnani F, Pappas CG, Crook T, Magafa V, Cordopatis P, Ishiguro S, Ohta N, Selent J, Bosnyak S, Jones ES, Gerothanassis IP, Tamura M, Widdop RE, Tzakos AG. ACS Chem Biol. 2014;9:1420-5.